Label: GUAIFENESIN tablet

  • NDC Code(s): 11673-840-27, 11673-840-28
  • Packager: TARGET CORPORATION
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated November 18, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredients (in each extended-release bi-layer tablet)

    Guaifenesin 1200 mg

  • purpose

    Expectorant

  • Uses

    helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

  • Do not use

     for children under 12 years of age

  • Ask a doctor before use if you have

     persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
     cough accompanied by too much phlegm (mucus)

  • Stop use and ask a doctor if

    cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

  • If pregnant or breast-feeding,

    ask a health professional before use.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)

  • Directions

     do not crush, chew, or break tablet
     take with a full glass of water
     this product can be administered without regard for timing of meals
     adults and children 12 years of age and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours
     children under 12 years of age: do not use

  • Other information

     Tamper evident: Do not use if carton is open or if printed seal on blister is broken or missing.
     store between 20-25°C (68-77°F)

  • Inactive ingredients

    carbomer homopolymer type B; hypromellose; magnesium stearate; microcrystalline cellulose; sodium starch glycolate

  • Questions?

    Contact 1-877-770-3183 Mon-Fri 8:00 AM EST to 5:00 PM PST.

  • Principal display panel

    14ct28ct

  • INGREDIENTS AND APPEARANCE
    GUAIFENESIN 
    guaifenesin tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-840
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN1200 mg
    Inactive Ingredients
    Ingredient NameStrength
    SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) (UNII: Z135WT9208)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeOVAL (Elliptical) Size22mm
    FlavorImprint Code G;1200
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:11673-840-2714 in 1 BLISTER PACK; Type 0: Not a Combination Product08/01/2024
    2NDC:11673-840-2828 in 1 BLISTER PACK; Type 0: Not a Combination Product08/01/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21342008/01/2024
    Labeler - TARGET CORPORATION (006961700)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!